Search - tctmd.com

Displaying 441 - 460 of 648

Sort: Relevancy | Date

Presentation TCT 2014

TAVR Case Presentation: Introduction and Challenges

Presenter: Run-Lin Gao, Martin B. Leon, Jian'an Wang

September 13, 2014

Presentation TCT 2014

Thoughtful Perspectives on the Futile Patient with Aortic Stenosis

Presenter: Martin B. Leon, Neil E. Moat, Ariel Finkelstein, Robert A. Guyton

September 13, 2014

Presentation TCT 2014

TCT 687: One-Year Outcomes of Transfemoral Transcatheter Versus Surgical Aortic Valve Replacement in Patients with Intermediate Surgical Risk: The Italian OBSERVANT Study

Presenter: Martin B. Leon, Neil E. Moat, Ariel Finkelstein, Marco Barbanti

September 13, 2014

Presentation TCT 2014

Updates from PARTNER 2A and Sapien 3 in Intermediate-Risk Patients

Presenter: Martin B. Leon, Neil E. Moat, Ariel Finkelstein, Vinod H. Thourani

September 13, 2014

Presentation TCT 2014

Updates from SURTAVI in Intermediate-Risk Patients

Presenter: Martin B. Leon, Neil E. Moat, Ariel Finkelstein, Patrick W. Serruys

September 13, 2014

Presentation TCT 2014

Changing Roles and Opportunities for the Cardiac Surgeon in the TAVR Era

Presenter: A. Pieter Kappetein, Martin B. Leon, Howard C. Herrmann, Vinod H. Thourani

September 13, 2014

Presentation TCT 2014

Evolution of the Heart Valve Team Concept in the Maturation Phase of TAVR

Presenter: A. Pieter Kappetein, Martin B. Leon, Howard C. Herrmann, Ganesh Manoharan

September 13, 2014

Presentation TCT 2014

Reflections on Transcatheter Aortic Valve Therapies from BAV to TAVR: Greatest Disappointments, Surprises, and Achievements

Presenter: A. Pieter Kappetein, Martin B. Leon, Howard C. Herrmann, Alain G. Cribier

September 13, 2014

Presentation TCT 2014

Important Changes in the New 2014 ACC/AHA Aortic Valve Guidelines: Aligning Definitions of Aortic Stenosis Severity with Treatment Recommendations

Presenter: A. Pieter Kappetein, Martin B. Leon, Howard C. Herrmann, Robert O. Bonow

September 13, 2014

Presentation TCT 2014

Perspectives on the Current Controversies in TAVR for 2014

Presenter: Martin B. Leon

September 13, 2014

News Conference News TCT 2014

Michael J. Mack, MD, Becomes First Surgeon to Receive TCT Career Achievement Award

September 13, 2014

News Industry News

Elixir Medical Announces Schedule of Programs for TCT 2014

September 08, 2014

Presentation BRS 2014

What I Learned That Was Most Important: Technique in Complex Lesions

Presenter: Martin B. Leon

July 26, 2014

Presentation BRS 2014

Emerging BRS Landscape: MeRes from Meril Lifescience

Presenter: Martin B. Leon

July 26, 2014

News Daily News

VIVID登记处：瓣中瓣TAVR的益处取决于手术后退化生物瓣膜的大小、状态

July 10, 2014

News Daily News

VIVID Registry: Benefit of Valve-in-Valve TAVR Depends on Size, Status of Failed Surgical Bioprosthesis

July 10, 2014

News Daily News

Registro VIVID: El Beneficio de la TAVR Válvula dentro de Otra Válvula Depende del Tamaño y del Estatus de Bioprótesis Quirúrgica Fallida

July 10, 2014

News Daily News

Una Mayor Regresión Precoz de la Masa VI Post-TAVR Reduce las Rehospitalizaciones

June 27, 2014

News Daily News

Greater Early LV Mass Regression After TAVR Reduces Rehospitalization

June 27, 2014

News Features

Renal Denervation 2.0: Laying Out the Road to Recovery from Symplicity HTN-3

June 24, 2014

Advertisement

TAVR Case Presentation: Introduction and Challenges

Thoughtful Perspectives on the Futile Patient with Aortic Stenosis

TCT 687: One-Year Outcomes of Transfemoral Transcatheter Versus Surgical Aortic Valve Replacement in Patients with Intermediate Surgical Risk: The Italian OBSERVANT Study

Updates from PARTNER 2A and Sapien 3 in Intermediate-Risk Patients

Updates from SURTAVI in Intermediate-Risk Patients

Changing Roles and Opportunities for the Cardiac Surgeon in the TAVR Era

Evolution of the Heart Valve Team Concept in the Maturation Phase of TAVR

Reflections on Transcatheter Aortic Valve Therapies from BAV to TAVR: Greatest Disappointments, Surprises, and Achievements

Important Changes in the New 2014 ACC/AHA Aortic Valve Guidelines: Aligning Definitions of Aortic Stenosis Severity with Treatment Recommendations

Perspectives on the Current Controversies in TAVR for 2014

Michael J. Mack, MD, Becomes First Surgeon to Receive TCT Career Achievement Award

Elixir Medical Announces Schedule of Programs for TCT 2014

What I Learned That Was Most Important: Technique in Complex Lesions

Emerging BRS Landscape: MeRes from Meril Lifescience

VIVID登记处：瓣中瓣TAVR的益处取决于手术后退化生物瓣膜的大小、状态

VIVID Registry: Benefit of Valve-in-Valve TAVR Depends on Size, Status of Failed Surgical Bioprosthesis

Registro VIVID: El Beneficio de la TAVR Válvula dentro de Otra Válvula Depende del Tamaño y del Estatus de Bioprótesis Quirúrgica Fallida

Una Mayor Regresión Precoz de la Masa VI Post-TAVR Reduce las Rehospitalizaciones

Greater Early LV Mass Regression After TAVR Reduces Rehospitalization

Renal Denervation 2.0: Laying Out the Road to Recovery from Symplicity HTN-3

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content